Cardiac natriuretic peptides for diagnosis and risk stratification in heart failure: Influences of left ventricular dysfunction and coronary artery disease on cardiac hormonal activation

European Journal of Clinical Investigation

Volumn 28, Issue 8, 1998, Pages 636-642

  Selvais, P L ^a   Donckier, J E ^a   Robert, A ^a   Laloux, O ^a   Van Linden, F ^a   Ahn, S ^a   Ketelslegers, J M ^a   Rousseau, M F ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Coronary disease; Heart failure; Natriuretic peptides; Neurohormones

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; HORMONE PRECURSOR; NATRIURETIC FACTOR;

ARTICLE; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE SEVERITY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HUMAN; MALE; MORTALITY; OUTCOMES RESEARCH; OUTPATIENT; PRIORITY JOURNAL; PROGNOSIS;

AGED; ATRIAL NATRIURETIC FACTOR; CHRONIC DISEASE; CORONARY DISEASE; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; OUTPATIENTS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; SURVIVAL ANALYSIS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0031822774     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1998.00338.x     Document Type: Article

References (29)

1. Bonow RO. New insights into the cardiac natriuretic peptides. Circulation 1996; 93: 1946-50.
2. Anderson JV, Donckier J, McKenna WJ, Bloom SR. The plasma release of atrial natriuretic peptide in man. Clin Sci 1986; 71: 151-5.
3. Burnett JCJ, Kao PC, Hu DC, et al. Atrial natriuretic peptide elevation in congestive heart failure in the human. Science 1986; 231: 1145-7.
4. Donckier J, De Coster P, Vanoverschelde JL, et al. Atrial natriuretic factor, cardiac volumes and filling pressures during exercise in congestive heart failure. Eur Heart J 1991; 12: 332-7.
5. Sundsfjord JA, Thibault G, Larochelle P, Cantin A. Identification and plasma concentrations of the N-terminal fragment of proatrial natriuretic factor in man. J Clin Endocrinol Metab 1988; 66: 605-10.
6. Azizi C, Maistre G, Kalotka H, et al. Plasma levels and molecular forms of proatrial natriuretic peptides in healthy subjects and in patients with congestive heart failure. J Endocrinol 1996; 148: 51-7.
7. Hall C, Aaberge L, Stoke O. In vitro stability of N-terminal proatrial natriuretic factor in unfrozen samples: an important prerequisite for its use as a biochemical parameter of atrial pressure in clinical routine (letter). Circulation 1995; 191: 911.
8. Nelesen RA, Dimsdale JE, Ziegler MG. Plasma atrial natriuretic peptide is unstable under most storage conditions. Circulation 1992; 86: 463-6.
9. Cleland JGF, Ward S, Dutka D, Habib F, Impallomeni M, Morton IJ. Stability of plasma concentrations of N and C terminal atrial natriuretic peptides at room temperature. Heart 1996; 75: 410-3.
10. Mukoyama M, Nakao K, Hosoda K, et al. Brain natriuretic peptide as a novel cardiac hormone in humans. J Clin Invest 1991; 87: 1402-12.
11. Davidson NC, Coutie WJ, Struthers AD. N-terminal proatrial natriuretic peptide and brain natriuretic peptide are stable for up to 6 hours in whole blood in vitro (letter). Circulation 1995; 91: 1276.
12. Francis GS, Benedict C, Johnstone DE, et al. for the SOLVD investigators. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. Circulation 1990; 82: 1724-9.
13. Lerman A, Gibbons RJ, Rodeheffer RJ, et al. Circulating N-terminal atrial natriuretic peptide as a marker for symptomless left-ventricular dysfunction. Lancet 1993; 341: 1105-9.
14. Friedl W, Mair J, Thomas S, Pichler M, Puschendorf B. Natriuretic peptides and cyclic guanosine 3′,5′-monophosphate in asymptomatic and symptomatic left ventricular dysfunction. Heart 1996; 76: 129-36.
15. Omland T, Aakvaag A, Vik-Mo H. Plasma cardiac natriuretic peptide determination as a screening test for the detection of patients with mild left ventricular impairment. Heart 1996; 76: 232-7.
16. Davidson NC, Naas AA, Hanson JK, Kennedy NSJ, Coutie WJ, Struthers AD. Comparison of atrial natriuretic peptide, B-type natriuretic peptide, and N-terminal proatrial natriuretic peptide as indicators of left ventricular systolic dysfunction. Am J Cardiol 1996; 77: 828-31.
17. Choy AMJ, Darbar D, Lang CC, et al. Detection of left ventricular dysfunction after acute myocardial infarction: comparison of clinical, echocardiographic, and neurohormonal method. Br Heart J 1994; 72: 16-22.
18. Swedberg K, Eneroth P, Kjekshus J, Wilhelmsen L. for the CONSENSUS Trial Study Group. Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. Circulation 1990; 82: 1730-6.
19. Hall C, Rouleau JL, Moye L, et al. N-terminal proatrial natriuretic factor. An independent predictor of long-term prognosis after myocardial infarction. Circulation 1994; 89: 1934-42.
20. Rouleau JL, Packer M, Moye L, et al. Prognostic value of neurohumoral activation in patients with an acute myocardial infarction: effect of captopril. J Am Coll Cardiol 1994; 24: 583-91.
21. Omland T, Bonarjee WS, Lie RT, Caidahl K. Neurohumoral measurements as indicators of long-term prognosis after acute myocardial infarction. Am J Cardiol 1995; 76: 230-5.
22. Omland T, Aakvaag A, Bonarjee VSS, et al. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natrirutic peptide and N-terminal proatrial natriuretic peptide. Circulation 1996; 93: 1963-9.
23. Arakawa N, Nakamura M, Aoki H, Hiramori K. Plasma brain natriuretic peptide concentrations predict survival after acute myocardial infarction. J Am Coll Cardiol 1996; 27: 1656-61.
24. Gottlieb SS, Kukin ML, Ahern D, Packer M. Prognostic importance of atrial natriuretic peptide in patients with chronic heart failure. J Am Coll Cardiol 1989; 13: 1534-9.
25. Benedict CR, Shelton B, Johnstone DE, et al. for the SOLVD investigators. Prognostic significance of plasma norepinephrine in patients with asymptomatic left ventricular dysfunction. Circulation 1996; 94: 690-7.
26. Donckier J, De Coster P, Buysschaert M, et al. Effect of exercise on atrial natriuretic factor and cardiac function in men and women. Eur J Clin Invest 1988; 18: 415-9.
27. Ogawa T, Linz W, Stevenson M, et al. Evidence for load-dependent and load-independent determinants of cardiac natriuretic peptide production. Circulation 1996; 93: 2059-67.
28. Donckier J, Anderson JV, Yeo T, Bloom SR. Diurnal rhythm in the plasma concentration of atrial natriuretic peptide. N Engl J Med 1986; 315: 710-1 (letter).
29. Pousset F, Isnard R, Lechat P, et al. Prognostic value of plasma endothelin-1 in patients with chronic heart failure. Eur Heart J 1997; 18: 254-8.